Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joe F. Lee is active.

Publication


Featured researches published by Joe F. Lee.


Bioorganic & Medicinal Chemistry Letters | 2000

Synthesis and NK1/NK2 receptor activity of substituted-4(Z)-(methoxyimino)pentyl-1-piperazines

Pauline C. Ting; Joe F. Lee; John C. Anthes; Neng-Yang Shih; John J. Piwinski

A series of 5-[(3,5-bis(trifluoromethyl)phenyl)methoxy]-3-(3,4-dichlorophenyl)-4(Z)- (methoxyimino)pentyl-1-piperazines was prepared and their affinity for the NK1 and NK2 receptors investigated. Compounds 7f, 10o, 10r, and 10s were found to be our most potent inhibitors.


Bioorganic & Medicinal Chemistry Letters | 1998

Synthesis of a series of sulfinic acid analogs of GABA and evaluation of their GABAB receptor affinities

Nicholas I. Carruthers; James M. Spitler; Shing-Chun Wong; David J. Blythin; Xiao Chen; Ho-Jane Shue; Hoyan S. She; Joe F. Lee; Charles A. Rizzo; Pauline C. Ting; Robert E. West

A series of gamma-aminobutyric acid (GABA) 1 analogs was prepared in which the carboxylic acid group of GABA was replaced with a sulfinic acid group and their affinity for the GABAB receptor investigated.


Bioorganic & Medicinal Chemistry Letters | 2010

The discovery of novel tartrate-based TNF-[alpha] converting enzyme (TACE) inhibitors

Kristin E. Rosner; Zhuyan Guo; Peter Orth; Gerald W. Shipps; David B. Belanger; Tin Yau Chan; Patrick J. Curran; Chaoyang Dai; Yongqi Deng; Vinay M. Girijavallabhan; Liwu Hong; Brian J. Lavey; Joe F. Lee; Dansu Li; Zhidan Liu; Janeta Popovici-Muller; Pauline C. Ting; Henry A. Vaccaro; Li Wang; Tong Wang; Wensheng Yu; Guowei Zhou; Xiaoda Niu; Jing Sun; Joseph A. Kozlowski; Daniel Lundell; Vincent Madison; Brian Mckittrick; John J. Piwinski; Neng Yang Shih

A novel series of TNF-alpha convertase (TACE) inhibitors which are non-hydroxamate have been discovered. These compounds are bis-amides of L-tartaric acid (tartrate) and coordinate to the active site zinc in a tridentate manner. They are selective for TACE over other MMPs. We report the first X-ray crystal structure for a tartrate-based TACE inhibitor.


Bioorganic & Medicinal Chemistry Letters | 2002

The synthesis of substituted fluorenes as novel non-imidazole histamine H3 inhibitors

Pauline C. Ting; Joe F. Lee; Margaret M. Albanese; Wing C. Tom; Daniel M. Solomon; Robert G. Aslanian; Neng-Yang Shih; Robert E. West

A novel non-imidazole fluorene oxime 1a has been identified as a histamine H(3) inhibitor, and its structure-activity relationship has been evaluated.


Bioorganic & Medicinal Chemistry Letters | 2001

Synthesis of substituted 4(Z)-(methoxyimino)pentyl-1-piperidines as dual NK1/NK2 inhibitors

Pauline C. Ting; Joe F. Lee; John C. Anthes; Neng-Yang Shih; John J. Piwinski

The NK1 and NK2 receptor activity of a series of 5-[(3,5-bis(trifluoromethyl)phenyl)methoxy]-3-(3,4-dichlorophenyl)-4(Z)-(methoxyimino)pentyl-1-piperidines was evaluated. Compounds 11d, 11e, 11f, 12a, and 12k were found to be our most potent inhibitors.


Journal of Medicinal Chemistry | 1988

Antiallergy agents. 1. Substituted 1,8-naphthyridin-2(1H)-ones as inhibitors of SRS-A release

Margaret H. Sherlock; James J. Kaminski; Wing C. Tom; Joe F. Lee; Shing Chun Wong; William Kreutner; Robert W. Bryant; Andrew T. McPhail


Bioorganic & Medicinal Chemistry Letters | 2005

The synthesis of substituted bipiperidine amide compounds as CCR3 antagonists

Pauline C. Ting; Joe F. Lee; Jie Wu; Shelby P. Umland; Robert G. Aslanian; Jianhua Cao; Youhao Dong; Charles G. Garlisi; Eric J. Gilbert; Ying Huang; James Jakway; Joseph M. Kelly; Zhidan Liu; Stuart W. McCombie; Himanshu Shah; Fang Tian; Yuntao Wan; Neng-Yang Shih


Journal of Medicinal Chemistry | 1990

Substituted 1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-ones as potential antiinflammatory agents.

Pauline C. Ting; James J. Kaminski; Margaret H. Sherlock; Wing C. Tom; Joe F. Lee; Robert W. Bryant; Arthur S. Watnick; Andrew T. McPhail


Bioorganic & Medicinal Chemistry Letters | 2006

Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists

Michael Y. Berlin; Pauline C. Ting; Wayne Vaccaro; Robert G. Aslanian; Kevin D. Mccormick; Joe F. Lee; Margaret M. Albanese; Mwangi W. Mutahi; John J. Piwinski; Neng-Yang Shih; Luli Duguma; Daniel M. Solomon; Wei Zhou; Rosy Sher; Leonard Favreau; Matthew Bryant; Walter A. Korfmacher; Cymbelene Nardo; Robert E. West; John C. Anthes; Shirley M. Williams; Ren-Long Wu; H. Susan She; Maria A. Rivelli; Michel R. Corboz; John A. Hey


american thoracic society international conference | 2010

Pharmacology Of SCH900182, A Potent, Selective Inhibitor Of PDE4 For Inhaled Administration

Richard W. Chapman; Aileen House; Jennifer Richard; Xiomara Fernandez; Howard Jones; Dan Prelusky; James Lamca; Peng Wang; Dan Lundell; Wu Ping; Reshma Kuvelkar; John C. Anthes; Pauline C. Ting; Joe F. Lee; Rongze Kuang; Robert G. Aslanian; Jonathan E. Phillips

Collaboration


Dive into the Joe F. Lee's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge